Skip to content
- 2023
- New biologic (Ab-IPL-IL-17) for IL-17-mediated diseases: identification of the bioactive sequence (nIL-17) for IL-17A/F function. Saviano A, Manosour AA, Raucci F, Merlino F, Marigliano N, Schettino A, Wahid M, Begum J, Filer A, Manning JE, Casillo GM, Piccolo M, Ferraro MG, Marzano S, Russomanno P, Bellavita R, Irace C, Amato J, Alfaifi M, Rimmer P, Iqbal T, Pieretti S, Vellecco V, Caso F, Costa L, Giacomelli R, Scarpa R, Cirino G, Bucci M, McGettrick HM, Grieco P, Iqbal AJ, Maione F.Ann Rheum Dis. 2023 Nov;82(11):1415-1428. doi: 10.1136/ard-2023-224479. Epub 2023 Aug 14.PMID: 37580108 Free PMC article
- Synthesis of temporin L hydroxamate-based peptides and evaluation of their coordination properties with iron (III). Bellavita R, Leone L, Maione A, Falcigno L, D’Auria G, Merlino F, Grieco P, Nastri F, Galdiero E, Lombardi A, Galdiero S, Falanga A.Dalton Trans. 2023 Mar 28;52(13):3954-3963. doi: 10.1039/d2dt04099a.PMID: 36744636
- Unveiling the mechanism of action of acylated temporin L analogues against multidrug-resistant Candida albicans. Bellavita R, Falanga A, Merlino F, D’Auria G, Molfetta N, Saviano A, Maione F, Galdiero U, Catania MR, Galdiero S, Grieco P, Roscetto E, Falcigno L, Buommino E.J Enzyme Inhib Med Chem. 2023 Dec;38(1):36-50. doi: 10.1080/14756366.2022.2134359.PMID: 36305289
- Synthetic Amphipathic β-Sheet Temporin-Derived Peptide with Dual Antibacterial and Anti-Inflammatory Activities. Bellavita R, Buommino E, Casciaro B, Merlino F, Cappiello F, Marigliano N, Saviano A, Maione F, Santangelo R, Mangoni ML, Galdiero S, Grieco P, Falanga A.Antibiotics (Basel). 2022 Sep 21;11(10):1285. doi: 10.3390/antibiotics11101285.PMID: 36289944
- Ad-hoc modifications of cyclic mimetics of SOCS1 protein: Structural and functional insights. La Manna S, Fortuna S, Leone M, Mercurio FA, Di Donato I, Bellavita R, Grieco P, Merlino F, Marasco D.Eur J Med Chem. 2022 Dec 5;243:114781. doi: 10.1016/j.ejmech.2022.114781. Epub 2022 Sep 19.PMID: 36152385